Logo image of JCI

JOHNSON CONTROLS INTERNATION (JCI) Stock Fundamental Analysis

NYSE:JCI - IE00BY7QL619 - Common Stock

109.27 USD
+0.81 (+0.75%)
Last: 8/27/2025, 8:04:00 PM
109.27 USD
0 (0%)
After Hours: 8/27/2025, 8:04:00 PM
Fundamental Rating

4

Overall JCI gets a fundamental rating of 4 out of 10. We evaluated JCI against 41 industry peers in the Building Products industry. While JCI is still in line with the averages on profitability rating, there are concerns on its financial health. JCI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year JCI was profitable.
JCI had a positive operating cash flow in the past year.
Each year in the past 5 years JCI has been profitable.
JCI had a positive operating cash flow in each of the past 5 years.
JCI Yearly Net Income VS EBIT VS OCF VS FCFJCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

The Return On Assets of JCI (5.14%) is comparable to the rest of the industry.
JCI has a Return On Equity (14.09%) which is comparable to the rest of the industry.
The Return On Invested Capital of JCI (6.37%) is worse than 70.73% of its industry peers.
JCI had an Average Return On Invested Capital over the past 3 years of 6.34%. This is significantly below the industry average of 12.73%.
The 3 year average ROIC (6.34%) for JCI is below the current ROIC(6.37%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.14%
ROE 14.09%
ROIC 6.37%
ROA(3y)4%
ROA(5y)3.49%
ROE(3y)10.39%
ROE(5y)8.82%
ROIC(3y)6.34%
ROIC(5y)6%
JCI Yearly ROA, ROE, ROICJCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

JCI has a Profit Margin of 11.11%. This is in the better half of the industry: JCI outperforms 65.85% of its industry peers.
In the last couple of years the Profit Margin of JCI has declined.
The Operating Margin of JCI (12.98%) is comparable to the rest of the industry.
JCI's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 38.13%, JCI is doing good in the industry, outperforming 68.29% of the companies in the same industry.
In the last couple of years the Gross Margin of JCI has grown nicely.
Industry RankSector Rank
OM 12.98%
PM (TTM) 11.11%
GM 38.13%
OM growth 3Y-3.83%
OM growth 5Y11.73%
PM growth 3Y2.41%
PM growth 5Y-20.69%
GM growth 3Y1.1%
GM growth 5Y1.86%
JCI Yearly Profit, Operating, Gross MarginsJCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. Health

2.1 Basic Checks

JCI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, JCI has less shares outstanding
Compared to 5 years ago, JCI has less shares outstanding
Compared to 1 year ago, JCI has a worse debt to assets ratio.
JCI Yearly Shares OutstandingJCI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
JCI Yearly Total Debt VS Total AssetsJCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

JCI has an Altman-Z score of 2.22. This is not the best score and indicates that JCI is in the grey zone with still only limited risk for bankruptcy at the moment.
JCI has a Altman-Z score of 2.22. This is amonst the worse of the industry: JCI underperforms 80.49% of its industry peers.
The Debt to FCF ratio of JCI is 3.56, which is a good value as it means it would take JCI, 3.56 years of fcf income to pay off all of its debts.
JCI's Debt to FCF ratio of 3.56 is in line compared to the rest of the industry. JCI outperforms 56.10% of its industry peers.
JCI has a Debt/Equity ratio of 0.61. This is a neutral value indicating JCI is somewhat dependend on debt financing.
JCI has a Debt to Equity ratio (0.61) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 3.56
Altman-Z 2.22
ROIC/WACC0.9
WACC7.09%
JCI Yearly LT Debt VS Equity VS FCFJCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 0.96 indicates that JCI may have some problems paying its short term obligations.
JCI's Current ratio of 0.96 is on the low side compared to the rest of the industry. JCI is outperformed by 92.68% of its industry peers.
A Quick Ratio of 0.81 indicates that JCI may have some problems paying its short term obligations.
JCI has a Quick ratio of 0.81. This is in the lower half of the industry: JCI underperforms 78.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.81
JCI Yearly Current Assets VS Current LiabilitesJCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.91% over the past year.
Measured over the past years, JCI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.04% on average per year.
The Revenue for JCI has decreased by -25.43% in the past year. This is quite bad
Measured over the past years, JCI shows a decrease in Revenue. The Revenue has been decreasing by -0.86% on average per year.
EPS 1Y (TTM)8.91%
EPS 3Y11.73%
EPS 5Y13.04%
EPS Q2Q%-7.89%
Revenue 1Y (TTM)-25.43%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.86%
Sales Q2Q%-16.3%

3.2 Future

Based on estimates for the next years, JCI will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.97% on average per year.
Based on estimates for the next years, JCI will show a small growth in Revenue. The Revenue will grow by 2.52% on average per year.
EPS Next Y1.19%
EPS Next 2Y9.07%
EPS Next 3Y11.63%
EPS Next 5Y10.97%
Revenue Next Year-12.03%
Revenue Next 2Y-3.73%
Revenue Next 3Y-0.81%
Revenue Next 5Y2.52%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JCI Yearly Revenue VS EstimatesJCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
JCI Yearly EPS VS EstimatesJCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 28.83 indicates a quite expensive valuation of JCI.
65.85% of the companies in the same industry are cheaper than JCI, based on the Price/Earnings ratio.
JCI is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.14, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 24.76 indicates a rather expensive valuation of JCI.
JCI's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. JCI is more expensive than 65.85% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of JCI to the average of the S&P500 Index (22.80), we can say JCI is valued inline with the index average.
Industry RankSector Rank
PE 28.83
Fwd PE 24.76
JCI Price Earnings VS Forward Price EarningsJCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JCI is valued a bit more expensive than 78.05% of the companies in the same industry.
JCI's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 24.74
EV/EBITDA 23.87
JCI Per share dataJCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of JCI may justify a higher PE ratio.
PEG (NY)24.24
PEG (5Y)2.21
EPS Next 2Y9.07%
EPS Next 3Y11.63%

6

5. Dividend

5.1 Amount

JCI has a Yearly Dividend Yield of 1.41%.
Compared to an average industry Dividend Yield of 1.14, JCI pays a better dividend. On top of this JCI pays more dividend than 85.37% of the companies listed in the same industry.
Compared to the average S&P500 Dividend Yield of 2.34, JCI is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.41%

5.2 History

On average, the dividend of JCI grows each year by 6.63%, which is quite nice.
JCI has been paying a dividend for at least 10 years, so it has a reliable track record.
As JCI did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)6.63%
Div Incr Years4
Div Non Decr Years7
JCI Yearly Dividends per shareJCI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

JCI pays out 43.93% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of JCI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP43.93%
EPS Next 2Y9.07%
EPS Next 3Y11.63%
JCI Yearly Income VS Free CF VS DividendJCI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B
JCI Dividend Payout.JCI Dividend Payout, showing the Payout Ratio.JCI Dividend Payout.PayoutRetained Earnings

JOHNSON CONTROLS INTERNATION

NYSE:JCI (8/27/2025, 8:04:00 PM)

After market: 109.27 0 (0%)

109.27

+0.81 (+0.75%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)11-03 2025-11-03/amc
Inst Owners92.76%
Inst Owner Change0.2%
Ins Owners0.24%
Ins Owner Change-3.71%
Market Cap71.51B
Analysts74.07
Price Target115.03 (5.27%)
Short Float %1.08%
Short Ratio1.42
Dividend
Industry RankSector Rank
Dividend Yield 1.41%
Yearly Dividend1.49
Dividend Growth(5Y)6.63%
DP43.93%
Div Incr Years4
Div Non Decr Years7
Ex-Date06-23 2025-06-23 (0.37)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.91%
Min EPS beat(2)2.66%
Max EPS beat(2)3.16%
EPS beat(4)4
Avg EPS beat(4)4.76%
Min EPS beat(4)2.66%
Max EPS beat(4)7.63%
EPS beat(8)6
Avg EPS beat(8)2.5%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)8
Avg EPS beat(16)1.09%
Revenue beat(2)0
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-0.35%
Max Revenue beat(2)-0.26%
Revenue beat(4)2
Avg Revenue beat(4)0.76%
Min Revenue beat(4)-0.35%
Max Revenue beat(4)2.04%
Revenue beat(8)2
Avg Revenue beat(8)-0.71%
Revenue beat(12)3
Avg Revenue beat(12)-0.93%
Revenue beat(16)4
Avg Revenue beat(16)-1.05%
PT rev (1m)4.19%
PT rev (3m)24.67%
EPS NQ rev (1m)1.89%
EPS NQ rev (3m)2.58%
EPS NY rev (1m)1.18%
EPS NY rev (3m)2.07%
Revenue NQ rev (1m)-0.62%
Revenue NQ rev (3m)-0.06%
Revenue NY rev (1m)-1.06%
Revenue NY rev (3m)0.35%
Valuation
Industry RankSector Rank
PE 28.83
Fwd PE 24.76
P/S 3.56
P/FCF 24.74
P/OCF 21.26
P/B 4.52
P/tB N/A
EV/EBITDA 23.87
EPS(TTM)3.79
EY3.47%
EPS(NY)4.41
Fwd EY4.04%
FCF(TTM)4.42
FCFY4.04%
OCF(TTM)5.14
OCFY4.7%
SpS30.69
BVpS24.19
TBVpS-7.24
PEG (NY)24.24
PEG (5Y)2.21
Profitability
Industry RankSector Rank
ROA 5.14%
ROE 14.09%
ROCE 8.4%
ROIC 6.37%
ROICexc 6.52%
ROICexgc 18.68%
OM 12.98%
PM (TTM) 11.11%
GM 38.13%
FCFM 14.39%
ROA(3y)4%
ROA(5y)3.49%
ROE(3y)10.39%
ROE(5y)8.82%
ROIC(3y)6.34%
ROIC(5y)6%
ROICexc(3y)6.58%
ROICexc(5y)6.25%
ROICexgc(3y)23.86%
ROICexgc(5y)23.9%
ROCE(3y)8.19%
ROCE(5y)7.69%
ROICexcg growth 3Y-13.87%
ROICexcg growth 5Y1.5%
ROICexc growth 3Y-4.43%
ROICexc growth 5Y10.29%
OM growth 3Y-3.83%
OM growth 5Y11.73%
PM growth 3Y2.41%
PM growth 5Y-20.69%
GM growth 3Y1.1%
GM growth 5Y1.86%
F-Score7
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 3.56
Debt/EBITDA 2.93
Cap/Depr 66.39%
Cap/Sales 2.36%
Interest Coverage 250
Cash Conversion 101.3%
Profit Quality 129.54%
Current Ratio 0.96
Quick Ratio 0.81
Altman-Z 2.22
F-Score7
WACC7.09%
ROIC/WACC0.9
Cap/Depr(3y)65.14%
Cap/Depr(5y)62.93%
Cap/Sales(3y)2.17%
Cap/Sales(5y)2.16%
Profit Quality(3y)91.89%
Profit Quality(5y)135.07%
High Growth Momentum
Growth
EPS 1Y (TTM)8.91%
EPS 3Y11.73%
EPS 5Y13.04%
EPS Q2Q%-7.89%
EPS Next Y1.19%
EPS Next 2Y9.07%
EPS Next 3Y11.63%
EPS Next 5Y10.97%
Revenue 1Y (TTM)-25.43%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.86%
Sales Q2Q%-16.3%
Revenue Next Year-12.03%
Revenue Next 2Y-3.73%
Revenue Next 3Y-0.81%
Revenue Next 5Y2.52%
EBIT growth 1Y2.68%
EBIT growth 3Y-4.81%
EBIT growth 5Y10.77%
EBIT Next Year15.06%
EBIT Next 3Y12.31%
EBIT Next 5Y9.16%
FCF growth 1Y95.01%
FCF growth 3Y-6.18%
FCF growth 5Y20.42%
OCF growth 1Y67.36%
OCF growth 3Y-5.6%
OCF growth 5Y11.44%